婵犵數濮烽弫鍛婃叏閻戝鈧倿鎸婃竟鈺嬬秮瀹曘劑寮堕幋鐙呯幢闂備浇顫夊畷妯衡枖濞戞碍顐介柕鍫濇啒閺冨牊鏅查柛娑卞幗濞堟煡姊虹粙娆惧剰妞ゆ垵顦靛濠氭晲閸涘倻鍠庨埢搴ㄥ箚瑜庨鍕煛婢跺棙娅嗙紒璇茬墕椤繘鎼圭憴鍕/闂侀潧枪閸庢煡鎮甸姀銈嗏拺闁荤喐婢樺▓鈺呮煙閸戙倖瀚�
闂傚倸鍊搁崐鎼佸磹閹间礁纾圭€瑰嫭鍣磋ぐ鎺戠倞妞ゆ帊绀侀崜顓烆渻閵堝棗濮х紒鐘冲灴閻涱噣濮€閵堝棛鍘撻柡澶屽仦婢瑰棝宕濆鍡愪簻闁哄倸鐏濋顐ょ磼鏉堛劍宕岀€规洘甯掗~婵嬵敄閽樺澹曢梺鍛婄缚閸庢娊鎯屽▎鎾寸厱闁哄洢鍔岄悘鐘电磼閻欌偓閸ㄥ爼寮婚妸鈺傚亞闁稿本绋戦锟�/濠电姷鏁告慨鐑藉极閸涘﹥鍙忛柣鎴f閺嬩線鏌熼梻瀵割槮缁惧墽绮换娑㈠箣閺冣偓閸ゅ秹鏌涢妷顔煎⒒闁轰礁娲弻鏇$疀閺囩倫銉︺亜閿旇娅嶉柟顔筋殜瀹曟寰勬繝浣割棜闂傚倷绀侀幉鈥趁洪敃鍌氱;濠㈣埖鍔曢弰銉╂煟閹邦喖鍔嬮柍閿嬪灴閹綊骞侀幒鎴濐瀳濠电偛鎳忛崝娆撳蓟閻旂厧绀勯柕鍫濇椤忥拷/缂傚倸鍊搁崐鎼佸磹閹间礁纾归柟闂寸绾剧懓顪冪€n亝鎹i柣顓炴閵嗘帒顫濋敐鍛闂佽姤蓱缁诲倿婀侀梺缁樏Ο濠囧磿韫囨稒鐓曢柕濞垮劚閳ь剚鎮傚﹢渚€姊虹粙璺ㄧ闁告艾顑囩槐鐐哄箣閿旂晫鍘遍梺闈浨归崕閬嶅焵椤掆偓濞尖€愁嚕婵犳艾惟闁冲搫鍊告禍鐐烘⒑缁嬫寧婀扮紒瀣灴椤㈡棃鏁撻敓锟�
闂傚倸鍊搁崐鎼佸磹閹间礁纾瑰瀣捣閻棗銆掑锝呬壕濡ょ姷鍋為悧鐘汇€侀弴銏℃櫆闁芥ê顦純鏇㈡⒒婵犲骸浜滄繛璇у缁瑩骞嬮悩鐢靛箵濠德板€曢幊搴g不鐟欏嫮绠鹃柨婵嗛婢ь喖鈹戦垾鐐藉仮闁哄本鐩俊鎼佸Ψ閵夈垹浜鹃柛褎顨呴拑鐔兼煏婵炵偓娅嗛柛瀣閺屾稓浠﹂崜褉妲堝銈呴獜閹凤拷: 闂傚倸鍊搁崐宄懊归崶顒夋晪鐟滃秹婀侀梺缁樺灱濡嫰寮告担绯曟斀闁绘ê鐤囨竟妯肩棯閹规劦鍤欓柍瑙勫灴閹晠宕f径瀣€风紓鍌欑劍閸旀牠銆冩繝鍥ц摕闁跨喓濮撮悙濠囨煃鏉炴壆鍔嶉柣蹇庣窔濮婂搫鐣烽崶銊ユ畬缂備礁顦伴幐鎶藉春閻愬搫绠i柨鏃囨娴滃綊姊洪崨濠勬噧妞わ缚鍗抽獮鍐ㄢ枎韫囧﹥鏂€闂佸疇妫勫Λ妤佺濠靛鐓ラ柡鍥悘鑼偓娈垮枦椤曆囧煡婢舵劕顫呴柣妯荤墦閸旀垿寮婚弴锛勭杸濠电姴鍊搁埛澶愭⒑缂佹ḿ绠栭柣妤冨█楠炲啫鐣¢幍鍐茬墯闂佸憡鍔戦崝搴ㄦ儎鎼淬劍鈷戦柣鐔告緲濞堚晠鏌熼崙銈嗗 闂傚倸鍊搁崐鎼佸磹閹间礁纾瑰瀣椤愯姤鎱ㄥ鍡楀幊缂傚倹宀搁弻銈嗘叏閹邦兘鍋撻弽顐熷亾濮橆剦鐓奸柡宀嬬秮瀵噣宕掑顑跨帛缂傚倷璁查崑鎾愁熆閼搁潧濮囩紒鐘侯潐缁绘盯鏁愭惔鈥愁潻婵犵鈧偨鍋㈤柡灞剧☉椤繈顢楅崒婧炪劌螖閻橀潧浠﹂柣妤佹礉瑜颁礁顪冮妶鍡楀潑闁稿鎹囬弻锝堢疀閿濆懏鐝濋梺鍝勮嫰缁夊墎妲愰幒鎳崇喖鎳¢妶搴⑿ч梻鍌欑閹碱偆鎮锕€绀夐柟瀛樼箥閸ゆ洘銇勯幒鎴濐仼闁搞劌鍊归妵鍕籍閸ヨ埖缍堥柣搴$仛閻楁鎹㈠┑瀣仺闂傚牊绋愰幋鐑芥⒑闂堟稒顥滄い鎴濐樀閻涱喛绠涘☉娆愭闂佽法鍣﹂幏锟� 闂傚倸鍊搁崐鎼佸磹瀹勬噴褰掑炊瑜忛弳锕傛煕椤垵浜濋柛娆忕箳閳ь剙绠嶉崕閬嵥囬婊呯焼闁告劏鏂傛禍婊勩亜閹捐泛鏋庨柣蹇ョ秮閺岋綁濡烽濠氬仐濠殿喖锕︾划顖炲箯閸涙潙宸濆┑鐘插暙閸撳灚淇婇悙顏勨偓鏍垂閻㈢ǹ纾归柛顭戝枤閺嗭附绻濇繝鍌氭殜闁衡偓娴犲鐓曟い鎰Т閻忣噣鏌i幘瀛樺鞍缂佺粯绻堟慨鈧柨婵嗘閵嗘劖绻濋姀锝嗙【婵炲樊鍘奸悾鐑藉箣閿曗偓缁犺崵绱撴担鑲℃垵鈻嶅⿰鍫熺厵闁兼祴鏅炶棢闂侀€炲苯澧痪缁㈠弮椤㈡瑩骞嬮悩鐢碉紳闂佺ǹ鏈悷锕偹囨搴g<闂婎剚褰冮埀顒佺箞閻涱喛绠涘☉娆愭闂佽法鍣﹂幏锟� 闂傚倸鍊搁崐鎼佸磹閹间礁纾归柣鎴eГ閸ゅ嫰鏌ら崫銉︽毄濞寸姵纰嶆穱濠囨倷椤忓嫧鍋撻弽顓炲瀭闁汇垻枪閻ゎ噣鏌℃径瀣仼闁哄棴绠撻弻锟犲炊閵夈儳浠鹃梺缁樺笩閸嬫劙鍩€椤掆偓缁犲秹宕曢柆宥呯疇闁规壆澧楅崑鈺傜箾瀹割喕绨奸柛濠傜仛椤ㄣ儵鎮欓懠顑胯檸闂佸憡姊圭喊宥夊Φ閸曨垱鏅滈悹鍥皺娴狀垶姊哄Ч鍥у姶濞存粣缍佽棟鐟滅増甯楅悡娑㈡倶閻愭彃鈷旈柕鍡樺笒闇夐柣娆忔噽閻g敻鏌熼鐣屾噰妞ゃ垺顨婂畷鎺戔槈閸楃偞鍊犵紓鍌氬€搁崐鎼佸磹閻戣姤鍤勯柤鎼佹涧閸ㄦ棃鏌熺紒銏犳灈缂佺媭鍨堕弻銊╂偆閸屾稑顏� 闂傚倸鍊搁崐鎼佸磹閹间礁纾归柣鎴eГ閸ゅ嫰鏌涢锝嗙8闁逞屽厸閻掞妇鎹㈠┑瀣妞ゆ挾濯Σ鍗炩攽閻愬瓨缍戦柛姘儏宀e灝鈻庨幋婵愭闂佺鍕垫畷闁抽攱鍨堕妵鍕箳閸℃ぞ澹曠紓鍌欑椤︿即骞愰崘鑼殾鐟滅増甯掔壕濂告煟閹邦剦鍤熼柛妯绘倐濮婃椽宕ㄦ繝鍌氼潎闂佸憡鏌ㄧ€涒晠寮茬捄琛℃闁靛骏绱曢崢浠嬫⒑閸︻厼鍔嬫繛璇х畵瀹曢潧鈻庨幇鈺€绨诲銈嗘尨閸撴繄娑甸崼鏇熺厵闁荤喐婢橀顓㈡煙閻撳海绉虹€规洜鍏橀、妯衡攽閸埄妲板┑鐘垫暩婵兘銆傞鐐潟闁哄洢鍨圭壕鍧楁煙鏉堝墽鐣辩紒鐙€鍨堕弻銊╂偆閸屾稑顏� 闂傚倸鍊搁崐鎼佸磹閹间礁纾归柣鎴eГ閸ゅ嫰鏌涢幘鑼妽闁稿繑绮撻弻娑㈩敃閿濆棛顦ラ梺姹囧€濈粻鏍蓟閿濆绠涙い鎾跺О閸嬬偤姊洪崫鍕靛剰缂佸缍婂濠氬Ω閵夈垺鏂€闂佺硶妾ч弲婊嗗€撮梻鍌欑窔閳ь剛鍋涢懟顖炲储閸濄儳纾奸柤闀愮祷婢规﹢鏌i敐鍥у幋濠碘剝鎮傞崺鈩冩媴濞差亞宕滈梻鍌欒兌閹虫捇顢氶鐔峰灁妞ゆ挾鍊i敐鍚ゆ椽顢旈崨顏呭闂備胶鍘ч~鏇㈠磹閺囩偟鎽ュ┑鐘垫暩閸嬫盯鎯囨导鏉戠9闁哄浄绱曟禍钘夆攽閻樺灚鏆╁┑顔芥綑鐓ら柕鍫濇川閻棗顭块懜闈涘闁绘挶鍎甸弻锝夊即閻愭祴鍋撻崷顓涘亾濮樼偓瀚� 婵犵數濮烽弫鍛婃叏閻戣棄鏋侀柟闂寸绾惧鏌i幇顒佹儓闁搞劌鍊块弻娑㈩敃閿濆棛顦ョ紓浣哄С閸楁娊骞冭ぐ鎺戠倞鐟滃秹寮埀顒傜磽閸屾艾鈧湱鍠婂鍥ㄥ床婵炴垯鍨归獮銏′繆椤栨繃顏犲ù鐓庢处缁绘繂鈻撻崹顔界亶婵犵數鍋涢敃顏勵嚕婵犳艾鍗抽柣鏃堫棑缁愮偤姊虹化鏇炲⒉閽冮亶鏌e┑鍥ㄢ拻缂佽鲸鎸婚幏鍛村箵閹哄秴顥氶梺璇查閸樻粓宕戦幘缁樼厱闁哄洢鍔屾晶顔济归悪鈧崹璺侯潖濞差亜绠归柣鎰絻婵⊙囨⒑閸涘﹥纾搁柛鏂跨Ч閹﹢宕卞☉娆屾嫽婵炶揪绲介幉锟犲疮閻愮繝绻嗘い鎰剁到閻忓瓨顨ラ悙鑼闁轰焦鎹囬弫鎾绘晸閿燂拷 闂傚倸鍊搁崐鎼佸磹閹间礁纾圭€瑰嫭鍣磋ぐ鎺戠倞妞ゆ巻鍋撶痪鎯ь煼閺岀喖骞嶉纰辨毉闂佺ǹ顑冮崐婵嬪蓟閿熺姴绀冮柕濞у喚鏆梻浣规偠閸斿矂宕愰幖浣圭畳闂備胶枪缁绘劙宕ョ€n喖纾挎俊銈呮噺閻撴稑霉閿濆懏鍟炴い銉e灲閺岋紕浠︾拠鎻掝潎闂佽鍠撻崐婵嗙暦閹烘垟妲堟慨妤€妫旂槐锟� 闂傚倸鍊搁崐鎼佸磹瀹勬噴褰掑炊椤掑鏅悷婊冪箻閸┾偓妞ゆ帊鑳堕埢鎾绘煛閸涱垰孝闁伙絽鍢茶灒闁煎鍊楅惁鍫濃攽椤旀枻渚涢柛妯绘倐楠炴劙宕橀瑙f嫼闂佸憡绋戦敃銉﹀緞閸曨垱鐓曢柟鐐綑閸濊櫣鈧娲╃紞鈧紒鐘崇☉閳藉鈻庨幋婵嗘辈闂傚倷鑳剁划顖毭洪弽顓炵9闁革富鍘搁崑鎾愁潩閻愵剙顏� 婵犵數濮烽弫鍛婃叏閻戣棄鏋侀柟闂寸绾惧鏌i幇顒佹儓闁搞劌鍊块弻娑㈩敃閿濆棛顦ョ紓浣哄Т缂嶅﹪寮诲澶婁紶闁告洦鍓欏▍锝夋⒑缁嬭儻顫﹂柛鏃€鍨垮濠氭晲婢跺﹦顔掗悗瑙勬礀濞层劌危韫囨稒鈷戦柤濮愬€曢弸鎴︽倵濮橆剛澧︾€殿噮鍣e畷鐓庘攽閸℃瑧宕哄┑锛勫亼閸婃牠骞愰悙顒€鍨旀い鎾跺€i敐鍚ゆ椽顢旈崨顏呭闂備胶鍘ч~鏇㈠磹閺囩偟鎽ュ┑鐘垫暩閸嬫盯鎯囨导鏉戠9闁哄浄绱曟禍钘夆攽閻樺灚鏆╁┑顔芥綑鐓ら柕鍫濇川閻棗顭块懜闈涘闁绘挶鍎甸弻锝夊即閻愭祴鍋撻崷顓涘亾濮樼偓瀚� 闂傚倸鍊搁崐鎼佸磹閹间礁纾瑰瀣捣閻棗銆掑锝呬壕濡ょ姷鍋涢ˇ鐢稿极閹剧粯鍋愭い鏃傛嚀娴滈箖鏌涢幇闈涘箻闁汇倐鍋撴繝鐢靛仦閸ㄨ泛鐜婚崸妤佹櫖婵炴垯鍨洪埛鎴犵磼椤栨稒绀€濠⒀嗗皺缁辨帞鈧綆鍋勯悘瀵糕偓娈垮枛閹诧紕绮悢鐓庣劦妞ゆ帒瀚拑鐔兼煟閺冨倸甯剁紒鐘崇叀閺岀喐瀵肩€涙ɑ閿┑鐐茬墱閸樺墽妲愰幘瀛樺闁告繂瀚呴敐澶嬬厱闁靛ǹ鍎查崑銉р偓娈垮枛椤兘寮幘缁樺亹闁肩⒈鍓﹀Σ瑙勪繆閻愵亜鈧牠宕濊瀵板﹪宕稿灏栧亾閸涱喖顕遍悗娑櫱氶幏娲⒑閸涘﹦缂氶柛搴″船閳诲秹骞囬悧鍫㈠幍闂佸憡鍨崐鏍偓姘炬嫹
婵犵數濮烽弫鍛婃叏閻戣棄鏋侀柟闂寸绾惧潡鏌熺€电ǹ孝缂佽翰鍊濋弻锕€螣娓氼垱锛嗗┑鐐叉▕娴滄繈寮插⿰鍫熺厽闁逛即娼ф晶顕€骞栭弶鎴含婵﹨娅g划娆撳箰鎼淬垺瀚崇紓鍌欑椤戝棝骞戦崶顒€违闁告稑鐡ㄩ崐濠氭煠閹帒鍔ら柛娆忔濮婅櫣绱掑Ο鑽ゎ槬闂佺ǹ锕ゅ﹢閬嶅焵椤掍胶鍟查柟鍑ゆ嫹: 闂傚倸鍊搁崐鎼佸磹閹间礁纾瑰瀣捣閻棗銆掑锝呬壕濡ょ姷鍋為悧鐘汇€侀弴銏℃櫇闁逞屽墰婢规洝銇愰幒鎾跺幗闂佺鎻徊楣兯夋径宀€妫い鎾寸☉娴滈箖姊婚崒娆戭槮闁硅绻濆畷婵嬪即閻愬秶鍠愮换婵嬪磼濡嘲浜鹃柟鐑樻尵缁♀偓濠殿喗锕╅崢楣冨矗閸℃稒鈷戠紓浣股戠粈鈧梺绋匡工濠€閬嶅焵椤掍胶鍟查柟鍑ゆ嫹 闂傚倸鍊搁崐鎼佸磹瀹勬噴褰掑炊瑜忛弳锕傛煕椤垵浜濋柛娆忕箻閺屸剝寰勭€n亝顔呭┑鐐叉▕娴滄粌娲块梻浣规偠閸庤崵寰婇懞銉ь洸闁绘劦鍓氶崣蹇斾繆椤栨粌甯堕悽顖氱埣閺岋綀绠涢妷鈺傤€嶉梺闈涙搐鐎氱増鎱ㄩ埀顒勬煥濞戞ê顏柛锝勫嵆濮婄儤娼幍顔煎闂佸湱鎳撳ú顓烆嚕椤愶箑绠荤紓浣股戝▍銏ゆ⒑鐠恒劌娅愰柟鍑ゆ嫹 闂傚倸鍊搁崐鎼佸磹瀹勬噴褰掑炊瑜忛弳锕傛煟閵忊懚鍦玻濡ゅ懏鐓欓柟娈垮枛椤eジ鏌涚€e墎绡€闁哄本娲樺鍕醇濠靛棗顥欐繝鐢靛仦閸ㄦ儼褰滃┑鈩冨絻閻楁捇寮婚弴锛勭杸闁哄洨鍊妷鈺傜叆婵炴垶鐟уú瀛樻叏婵犲懏顏犻柟鐟板婵℃悂濡烽敂鎯х稈闂傚倷鑳堕幊鎾诲吹閺嶎厼绠柨鐕傛嫹 闂傚倸鍊搁崐鎼佸磹閻戣姤鍊块柨鏇炲€归崕鎴犳喐閻楀牆绗掗柡鍕╁劦閺屾盯寮撮妸銉т哗闂佹悶鍔岄崐鍨潖濞差亶鏁嗛柍褜鍓涚划鏃堟偨缁嬭法锛涢梺闈涚墕椤︿即鎮″☉銏$厱闁靛绲介崝姘舵煟韫囷絼閭柡灞剧⊕閹棃鍩ラ崨鏉挎儓闂備礁鎼悮顐﹀礉閹达箑绠栭柕鍫濐槸绾惧吋绻涢幋鐑囦緵濞寸》鎷� 闂傚倸鍊搁崐鎼佸磹閹间礁纾归柣鎴eГ閸婂潡鏌ㄩ弴鐐测偓褰掑磿閹寸姵鍠愰柣妤€鐗嗙粭鎺旂棯閹呯Ш闁哄矉绻濆畷鍫曞煛娴e湱鈧儳鈹戦悙鍙夊櫧濠电偐鍋撻梺鍝勭焿缁犳垼鐏掓繛鎾村嚬閸ㄩ亶鍩㈤幘鏂ユ斀闁绘劖褰冮幃鎴︽煟濡ゅ啫鈻堢€殿喖顭锋俊鎼佸煛閸屾矮绨介梻浣呵归張顒傜矙閹达富鏁傞柨鐕傛嫹 闂傚倸鍊搁崐鎼佸磹閹间礁纾归柣鎴eГ閸婂潡鏌ㄩ弴鐐测偓褰掑磿閹寸姵鍠愰柣妤€鐗嗙粭鎺旂棯閹勫仴闁哄本绋戣灃闁告剬鍛存7婵犵數鍋涘Ο濠冪濠婂嫬鍔旈梻鍌欑劍鐎笛兾涙担鑲濇盯宕熼顐㈡闂佺鍕垫畷闁抽攱鍨块幃褰掑箒閹烘垵顬堝┑鐐叉噺閸旀瑩寮婚悢鐓庣闁靛牆妫楅锟� 闂傚倸鍊搁崐鎼佸磹閹间礁纾归柣鎴eГ閸ゅ嫰鏌ら崫銉︽毄濞寸姵姘ㄧ槐鎾诲磼濞嗘帒鍘$紓渚囧櫘閸ㄥ爼濡撮崘顔煎窛閻庢稒锚娴犲ジ姊虹紒妯虹伇濠殿喓鍊濆畷鎴﹀Ω瑜忕壕濂告倵閿濆骸浜滄い鏇熺矒閺岋絾鎯旈鐓庘拫濠殿喖锕ㄥ▍锝夊箲閸曨垰惟闁靛濡囪ぐ姘舵⒒娴g儤鍤€闁搞倖鐗犻獮蹇涙晸閿燂拷 闂傚倸鍊搁崐鎼佸磹閹间礁纾归柣鎴eГ閸ゅ嫰鏌涢锝嗙缁炬儳娼¢弻锝夊閳惰泛婀辨竟鏇熺節濮橆厾鍘甸梺纭咁潐閸旓箓宕靛▎鎴犵<闁逞屽墯瀵板嫰骞囬鐓庣导闂備焦鎮堕崕顖炲礉瀹ュ洣鐒婇柣銏犳啞閻撴盯鏌涢埄鍐ㄥ闁逞屽墯缁诲牆顕f繝姘╅柍鍝勫€告禍鐐烘⒑缁嬫寧婀扮紒瀣灴椤㈡棃鏁撻敓锟� 闂傚倸鍊搁崐鎼佸磹閹间礁纾归柣鎴eГ閸ゅ嫰鏌涢锝嗙8闁逞屽厸閻掞妇鎹㈠┑瀣妞ゆ挾濯Σ鍗炩攽閻愬瓨缍戦柛姘儏宀e灝鈻庨幋婵愭闁荤喐鐟ョ€氼亞鎹㈤崱娑欑厪闁割偅绻冮崳娲煕閿濆懏璐$紒杈ㄥ浮閹晛鐣烽崶褉鎷伴梻浣告惈鐞氼偊宕濋幋锕€绠栭柕鍫濐槸绾惧吋绻涢幋鐑囦緵濞寸》鎷� 闂傚倸鍊搁崐鎼佸磹閹间礁纾圭€瑰嫭鍣磋ぐ鎺戠倞妞ゆ帒顦伴弲顏堟⒑閸濆嫮鈻夐柛妯垮亹缁牓宕掑☉姘鳖啎闂佺硶鍓濊摫閻忓浚鍘鹃惀顏堝箚瑜庨崑銉╂煛瀹€瀣?濞寸媴濡囬幏鐘诲箵閹烘埈娼涢梻鍌欑劍閻綊宕愬┑鍫笉闁哄稁鍘奸拑鐔兼煏婵炵偓娅嗛柛瀣閺屾稓浠﹂崜褉妲堝銈呴獜閹凤拷 闂傚倸鍊搁崐鎼佸磹閹间礁纾归柣鎴eГ閸ゅ嫰鏌ら崫銉︽毄濞寸姵纰嶆穱濠囨倷椤忓嫧鍋撻弽顓炲瀭闁汇垻枪閻ゎ噣鏌℃径瀣仼闁哄棴绠撻弻锟犲炊閵夈儳浠肩紓浣哄Х缁垶濡甸崟顖氱睄闁稿本绮嶉幉妯衡攽閳藉棗浜滈柟铏~蹇涙惞鐟欏嫬纾梺闈浨归崕鏌ユ偟閵忋倖鈷戦柣鐔告緲濞堚晠鏌熼崙銈嗗 缂傚倸鍊搁崐鎼佸磹閹间礁纾归柟闂寸绾惧綊鏌熼梻瀵割槮缁炬儳婀辩槐鎺斺偓锝庡亾缁扁晜绻涘顔荤盎閸ユ挳姊虹化鏇燁€嗛柡鍛矒椤㈡瑩寮崼鐔叉嫼閻熸粎澧楃敮妤呮晬閻旇櫣纾奸悹浣告贡缁♀偓閻庢鍣崑鍛崲濠靛鐐婇柕濞у啫姹查梻鍌欒兌缁垰煤閺嶎厼纾归柛锔诲幐閸嬫挸顫濋悙顒€顏� 婵犵數濮烽弫鍛婃叏閻戣棄鏋侀柟闂寸绾惧鏌i幇顒佹儓闁搞劌鍊块弻娑㈩敃閿濆棛顦ョ紓浣哄С閸楁娊寮诲☉銏╂晝闁挎繂妫涢ˇ銉х磼閻愵剙鍔ょ紓宥咃躬瀵鍨鹃幇浣告倯闁硅偐琛ラ埀顒€纾鎰版⒒娴h櫣甯涢悽顖涘浮閹ê顫濈捄浣曪箓鏌涢弴銊ョ仩缂佺姵濞婇弻鐔煎箹椤撶偟浠梺杞扮窔缁犳牠寮婚敐鍡樺劅闁靛繈鍨归弳锟犳⒑閻熸澘娈╅柟鍑ゆ嫹 闂傚倸鍊搁崐鎼佸磹閹间礁纾归柣鎴eГ閸ゅ嫰鏌涢锝嗙闁稿被鍔庨幉绋款吋婢舵ɑ鏅梺鎸庣箓椤︻垳绮诲鑸电厾闁告挻褰冮崢鍛婃叏鐟欏嫷娈滄慨濠冩そ瀹曘劍绻濋崒姣挎洟姊洪崫銉バi柣妤佺矌閸掓帡宕奸悢椋庣獮闂佸綊鍋婇崢楣冨矗閸℃稒鈷戠紓浣股戠粈鈧梺绋匡工濠€閬嶅焵椤掍胶鍟查柟鍑ゆ嫹 闂傚倸鍊搁崐鎼佸磹閹间礁纾归柣鎴eГ閸婂潡鏌ㄩ弴妤€浜惧銈庝簻閸熸潙鐣疯ぐ鎺濇晪闁告侗鍨伴弫绋库攽閻愬瓨灏伴柛鈺佸暣瀹曟垿骞橀幖顓燁啍闂佺粯鍔樼亸娆戠不婵犳碍鐓涘ù锝堫潐瀹曞矂鏌℃担瑙勫磳闁轰焦鎹囬弫鎾绘晸閿燂拷 婵犵數濮烽弫鍛婃叏閻戣棄鏋侀柛娑橈功缁犻箖鏌嶈閸撴氨鎹㈠☉娆愬闁告劕寮堕幖鎰棯閹规劦鍤欓柍瑙勫灴閹晠宕f径瀣€风紓鍌欒兌婵參宕归崼鏇炶摕闁靛ň鏅滈崑鍡涙煕鐏炲墽鈽夋い蹇ユ嫹 闂傚倸鍊搁崐鎼佸磹閹间礁纾归柣鎴eГ閸ゅ嫰鏌涢锝嗙闁稿被鍔庨幉鍛婃償閵娿儳鐣鹃梺鍝勫€哥花閬嶅醇椤忓牊鐓曟い鎰剁悼缁犳ɑ銇勯弬鎸庮棦婵﹨娅i幑鍕Ω閵夛妇褰氶梻浣烘嚀閸ゆ牠骞忛敓锟� 闂傚倸鍊搁崐鎼佸磹瀹勬噴褰掑炊椤掑鏅悷婊冪箻楠炴垿濮€閵堝懐鐤€濡炪倖鎸嗛崟闈涙櫖闂傚倸饪撮崑鍕洪敂鍓х煓闁瑰濮锋稉宥嗐亜閺嶎偄浠﹂柣鎾卞劦閺岋綁寮撮悙娴嬪亾閸︻厸鍋撳鐐 闂傚倸鍊搁崐鎼佸磹閹间礁纾归柣鎴eГ閸婂潡鏌ㄩ弴鐐测偓鍝ョ不閺嶎厽鐓曟い鎰剁稻缁€鈧紒鐐劤濞硷繝寮婚妶鍥ф瀳闁告鍋涢~顐︽⒑濞茶骞楅柣鐔叉櫊瀵鎮㈤崨濠勭Ф闂佽鍨庨崨顔ф帡姊绘担鑺ャ€冪紒鈧担鑲濇稑鈹戠€n亣鎽曢梺闈浥堥弲婊堝磻閸℃稒鐓曢悘鐐插⒔閳藉銇勮箛銉﹀ 闂傚倸鍊搁崐鎼佸磹瀹勬噴褰掑炊瑜忛弳锕傛煕椤垵浜濋柛娆忕箻閺屸剝寰勭€n亝顔呭┑鐐叉▕娴滄粓鎮″☉妯忓綊鏁愰崶褍濡哄┑鐐茬墦缁犳牕顫忓ú顏勭闁肩⒈鍓欑敮銉╂⒑缁嬫鍎忛柟鍐查叄閸┿垹顓兼径瀣汗缂傚倷鐒﹀玻鍧楀矗閸℃稒鈷戠紓浣股戠粈鈧梺绋匡工濠€閬嶅焵椤掍胶鍟查柟鍑ゆ嫹 闂傚倸鍊搁崐鎼佸磹閹间礁纾瑰瀣捣閻棗銆掑锝呬壕濡ょ姷鍋為悧鐘汇€侀弴銏犵厱婵﹩鍘介妵婵嬫煛娴gǹ鏆i柛鈹惧亾濡炪倖宸婚崑鎾绘煟濠婂喚鐓肩€规洖缍婇、娆戞喆閸曨厸鍋撴繝姘拺閻熸瑥瀚崝銈囩磼婢跺缍戦悡銈嗐亜閹惧崬鐏╅柡瀣╃窔閺岀喖宕滆鐢盯鏌¢崨顔藉€愰柡灞诲姂閹倝宕掑☉姗嗕紦
婵犵數濮烽弫鍛婃叏閻戣棄鏋侀柟闂寸绾惧鏌i幇顒佹儓闁搞劌鍊块弻娑㈩敃閿濆棛顦ョ紓浣哄Т缂嶅﹪寮诲澶婁紶闁告洦鍓欏▍锝夋⒑缁嬭儻顫﹂柛鏃€鍨垮濠氬Χ閸氥倕婀遍埀顒婄秵閸嬪懘鎮甸幒妤佲拺缂備焦锚缁楁帡鏌ㄩ弴銊ら偗鐎殿喖顭锋俊鎼佸煛閸屾矮绨介梻浣呵归張顒傜矙閹达富鏁傞柨鐕傛嫹: 闂傚倸鍊搁崐鎼佸磹閻戣姤鍊块柨鏇炲€归崕鎴犳喐閻楀牆绗掗柡鍕╁劦閺屾盯寮撮妸銉т哗闂佹悶鍔岄崐鍨潖濞差亶鏁嗛柍褜鍓涚划鏃堟偨缁嬭法锛涢梺闈涚墕椤︿即鎮″☉銏$厱闁靛绲介崝姘舵煟韫囷絼閭柡灞剧⊕閹棃鍩ラ崨鏉挎儓闂備礁鎼悮顐﹀礉閹达箑绠栭柕鍫濐槸绾惧吋绻涢幋鐑囦緵濞寸》鎷� 闂傚倸鍊搁崐鎼佸磹閹间礁纾圭€瑰嫭鍣磋ぐ鎺戠倞鐟滄粌霉閺嶎厽鐓忓┑鐐靛亾濞呭棝鏌涙繝鍌涘仴闁哄被鍔戝鎾倷濞村浜剧憸鐗堝笒绾惧鏌ㄩ悢鍝勑i柣鎾卞劦閺岋繝宕堕…鎴炵暥婵炲瓨绮屾晶浠嬪焵椤掆偓閸樻粓宕戦幘缁樼叆婵犻潧妫欓崳娲煕鐎c劌鍔﹂柡灞稿墲閹峰懐鎲撮崟顐わ紦闂備浇妗ㄩ悞锕傚箲閸ヮ剙鏋侀柟鍓х帛閺呮悂鏌ㄩ悤鍌涘 闂傚倸鍊搁崐鎼佸磹閹间礁纾圭€瑰嫭鍣磋ぐ鎺戠倞妞ゆ帒顦伴弲顏堟⒑閸濆嫮鈻夐柛妯垮亹缁牓宕奸悢绋垮伎濠碘槅鍨板ḿ锟犲传閾忓厜鍋撶憴鍕闁绘搫绻濆璇测槈閵忕姷鍔撮梺鍛婂姦娴滄牕危閸儲鈷戠紓浣姑粭鎺楁煟韫囨柨鍝哄┑锛勬暬瀹曠喖顢涘槌栧敽闂備浇顫夐幆宀勫垂闁秴鏋佸Δ锝呭暞閻撶喖骞栧ǎ顒€鐏柛鐔哥叀閺岀喖宕欓妶鍡楊伓 婵犵數濮烽弫鍛婃叏閻戣棄鏋侀柟闂寸绾惧鏌i幇顒佹儓闁搞劌鍊块弻娑㈩敃閿濆棛顦ョ紓浣哄Т缂嶅﹪寮诲澶婁紶闁告洦鍓欏▍锝夋⒑濞茶骞楁い銊ワ躬瀵顓奸崼顐n€囬梻浣告啞閹稿鎯勯鐐叉槬闁逞屽墯閵囧嫰骞掗幋婵囩亾濠电偛鍚嬮崝娆撳蓟閻斿搫鏋堥柛妤冨仒閸犲﹤螖閻橀潧浠滅紒缁橈耿瀵偊骞樼紒妯绘闂佽法鍣﹂幏锟� 闂傚倸鍊搁崐鎼佸磹閹间礁纾瑰瀣捣閻棗銆掑锝呬壕濡ょ姷鍋涢ˇ鐢稿极閹剧粯鍋愰柛鎰紦缂冩洟姊绘担铏瑰笡闁告梹岣挎禍绋库枎閹捐櫕杈堥梺鎸庢礀閸婂綊鎮¢悢鍏肩厪闊洤锕ラ崵澶愭煕閿旇骞樺☉鎾崇Ч閺屸€愁吋鎼粹€崇闂佺粯鎸堕崕鐢稿蓟閿濆鍗抽柣鎰ゴ閸嬫捇宕烽娑樹壕婵ḿ鍋撶€氾拷 婵犵數濮烽弫鍛婃叏閻戣棄鏋侀柟闂寸绾惧鏌i幇顒佹儓闁搞劌鍊块弻娑㈩敃閿濆棛顦ョ紓浣哄С閸楁娊骞冭ぐ鎺戠倞鐟滃秹寮埀顒傜磽閸屾艾鈧湱鍠婂鍥ㄥ床婵炴垯鍨归獮銏′繆椤栨繃顏犲ù鐓庢处缁绘繂鈻撻崹顔界亶婵犵數鍋涢敃顏勵嚕婵犳艾惟闁冲搫鍊告禍鐐烘⒑缁嬫寧婀扮紒瀣灴椤㈡棃鏁撻敓锟� 闂傚倸鍊搁崐鎼佸磹閹间礁纾归柟闂寸绾惧湱鈧懓瀚崳纾嬨亹閹烘垹鍊炲銈庡墻閸撴岸鎯勯姘辨殾闁绘梻鈷堥弫宥嗙箾閹寸伝鑲╃磾閺囥垺鈷掑ù锝呮啞鐠愶繝鏌涚€n偅灏い顏勫暣瀹曠ǹ螖閳ь剟寮告担鎼炩偓鎺戭潩閿濆懍澹曢梻浣告惈鐞氼偊宕濋幋锕€绠栭柕鍫濐槸绾惧吋绻涢幋鐑囦緵濞寸》鎷� 濠电姷鏁告慨鐑藉极閸涘﹥鍙忛柣銏犲閺佸﹪鏌″搴″箹缂佹劖顨嗘穱濠囧Χ閸涱収浠鹃梺鐟板暱閻倸顫忕紒妯诲閻熸瑥瀚禒鈺呮⒑閸涘﹥鐓ョ紒缁樺姍閸┿垽寮惔鎾搭潔濠电姴锕ら幊宥囩磾閺囥垺鈷掗柛灞剧懄缁佺増绻涙径瀣鐎规洘濞婇弫鍐磼濮橀硸鍞甸梻浣芥硶閸o箓骞忛敓锟� 闂傚倸鍊搁崐鎼佸磹閹间礁纾瑰瀣捣閻棗銆掑锝呬壕濡ょ姷鍋為悧鐘汇€侀弴銏℃櫇闁逞屽墰婢规洟宕烽鐘碉紲闁诲函缍嗛崑鎾舵閳哄倻绠剧€瑰壊鍠曠花濠氬炊閹绢喗鈷戦柟鑲╁仜閸旂數绱掗懠璺盒撶紒鍌氱Ч瀹曟粏顦存俊顐灦閺屸剝寰勭€i潧鍔屽┑鈩冨絻缂嶅﹪骞冨Δ鈧~婵嬫倷椤掆偓椤忥拷 闂傚倸鍊搁崐鎼佸磹閹间礁纾归柣鎴eГ閸婂潡鏌ㄩ弴鐐测偓鎼佸垂閸屾稓绡€闂傚牊渚楅崕鎰版煕婵犲倹鍋ラ柡灞诲姂瀵挳鎮欏ù瀣壕闁告稑饪撮弨浼存⒒閸屾瑨鍏岀紒顕呭灦瀹曟繂螖閸涱厽鐎梺鍛婄缚閸庢娊鎯岄崱妞绘斀闁绘ê寮舵径鍕煟閹惧崬鍔﹂柡宀嬬秮瀵挳鎮欏ù瀣壕闁革富鍘搁崑鎾愁潩閻愵剙顏� 婵犵數濮烽弫鍛婃叏閹绢喗鍎夊鑸靛姇缁狙囧箹鐎涙ɑ灏ù婊呭亾娣囧﹪濡堕崟顓炲闂佸憡鐟ョ换姗€寮婚悢铏圭<闁靛繒濮甸悘鍫ユ煟鎼淬垼澹樻い锔垮嵆婵$敻宕熼姘鳖唺闂佺懓鐡ㄧ换宥嗙婵傚憡鈷戦柦妯侯槸閺嗙喖鏌涢悩宕囧⒌鐎殿喖顭锋俊鎼佸煛閸屾矮绨介梻浣呵归張顒傜矙閹达富鏁傞柨鐕傛嫹 闂傚倸鍊搁崐鎼佸磹閹间礁纾归柣鎴eГ閸婂潡鏌ㄩ弴鐐测偓鍝ョ不閺嶎厽鐓曟い鎰剁稻缁€鈧紒鐐劤濞硷繝寮婚悢铏圭<婵☆垵娅i鍌炴⒑閸濆嫭锛旈梻鍕缁岃鲸绻濋崶鑸垫櫖濠电偛妫欑敮鈺呭礉閸涱厸鏀介柣鎰皺濮g偤鏌¢崨顖氣枅鐎殿喖顭锋俊鎼佸煛閸屾矮绨介梻浣呵归張顒傜矙閹达富鏁傞柨鐕傛嫹 婵犵數濮烽弫鍛婃叏閻戝鈧倿顢欓悙顒夋綗闂佸搫娲㈤崹鍦缂佹ḿ绠鹃柟瀛樼懃閻掓椽鏌℃担绋款伃闁哄本鐩俊鐑筋敊閻撳寒娼荤紓鍌欑劍閸旀牠銆冩繝鍥ц摕闁绘梻鍘х粻鏌ユ煙娴煎瓨娑ф繛鍫弮濮婃椽宕ㄦ繝鍌滀患婵犵數鍋愰崑鎾绘⒑閸濆嫯顫﹂柛鏃€鍨块獮鍐Χ婢跺﹦锛滃┑鐐村灦閿曗晜瀵奸敓锟� 闂傚倸鍊搁崐鎼佸磹閹间礁纾圭€瑰嫭鍣磋ぐ鎺戠倞妞ゆ巻鍋撶痪鎯ь煼閺岀喖骞嶉纰辨毉闂佺ǹ顑冮崐婵嬪蓟閿熺姴绀冮柕濞у喚鏆梻浣规偠閸斿矂宕愰崸妤€钃熺憸鎴犵不濞戙垺鏅查柛娑卞墰閸戣绻濋悽闈涗粶闁硅櫕鍔栫换娑㈠焵椤掑嫭鐓涢悘鐐额嚙婵倿鏌熼鍝勨偓婵嗙暦閹烘垟妲堟慨妤€妫旂槐锟� 闂傚倸鍊搁崐鎼佸磹閹间礁纾圭€瑰嫭鍣磋ぐ鎺戠倞妞ゆ巻鍋撶痪鎯ь煼閺岀喖骞嶉纰辨毉闂佺ǹ顑冮崐婵嬪蓟閿熺姴绀冮柕濞у喚鏆梻浣规偠閸斿矂宕愯ぐ鎺懳﹂柛鏇ㄥ灠閸愨偓闂侀潧臎閸涱垰甯撶紓鍌氬€烽懗鑸垫叏闂堟党娑㈠礃椤旇壈鎽曢梺闈浥堥弲婊堝磻閸℃稒鐓曢悘鐐插⒔閳藉銇勮箛銉﹀ 闂傚倸鍊搁崐鎼佸磹閹间礁纾圭€瑰嫭鍣磋ぐ鎺戠倞妞ゆ巻鍋撶痪鎯ь煼閺岀喖骞嶉纰辨毉闂佺ǹ顑冮崐婵嬪蓟閿熺姴绀冮柕濞у喚鏆梻浣规偠閸斿矂宕愰崸妤€钃熼柣鏂跨殱閺嬫棃鏌涢…鎴濇灍闁诲繑鎹囧娲川婵犲孩鐣烽悗鍏夊亾闁归棿绀侀拑鐔兼煏婵炵偓娅嗛柛瀣閺屾稓浠﹂崜褉妲堝銈呴獜閹凤拷 闂傚倸鍊搁崐鎼佸磹閹间礁纾瑰瀣捣閻棗銆掑锝呬壕濡ょ姷鍋為悧鐘汇€侀弴銏℃櫇闁逞屽墰婢规洝銇愰幒鎾充画濠电偛妫楃换鎰邦敂閳哄懏鐓曢柕濠忛檮椤ュ牓鏌″畝瀣暠閾伙絽銆掑鐓庣仭濡ゆ棃姊绘担鍛婃儓婵☆偄閰e畷鎰攽鐎n亣鎽曢梺闈浥堥弲婊堝磻閸℃稒鐓曢悘鐐插⒔閳藉銇勮箛銉﹀ 闂傚倸鍊搁崐鎼佸磹閹间礁纾归柣鎴eГ閸ゅ嫰鏌涢锝嗙缂佺姷濞€閺岀喖骞戦幇闈涙闁荤喐鐟辩粻鎾诲箖濡ゅ懏鏅查幖绮光偓鎰佹交闂備焦鎮堕崝宥囨崲閸儳宓侀柡宥庣仈鎼搭煈鏁嗛柍褜鍓氭穱濠囨嚃閳哄啯锛忛梺璇″瀻娴i晲鍒掗梻浣告惈鐞氼偊宕濋幋锕€绠栭柕鍫濐槸绾惧吋绻涢幋鐑囦緵濞寸》鎷� 闂傚倸鍊搁崐鎼佸磹閹间礁纾瑰瀣捣閻棗銆掑锝呬壕閻庤娲忛崕鎶藉焵椤掑﹦绉甸柍褜鍓﹂崣蹇曠礊娓氣偓閻涱噣骞掑Δ鈧粻濠氭煕濞嗘劌缂氶柣顓熷浮濮婄粯鎷呴崫銉ㄥ┑鈽嗗亯濞夋洜鍒掗崼鐔虹懝闁逞屽墮閻e嘲鈻庨幘鏉戜汗缂傚倷鐒﹀玻鍧楀矗閸℃稒鈷戠紓浣股戠粈鈧梺绋匡工濠€閬嶅焵椤掍胶鍟查柟鍑ゆ嫹
当前位置: 首页 > 期刊 > 《内分泌学杂志》 > 2003年第2期 > 正文
编号:10582756
The Severe Form of Hypertension Caused by the Activating S810L Mutation in the Mineralocorticoid Receptor Is Cortisone Related

     Abstract

    A gain of function mutation resulting in the substitution of leucine for serine at codon 810 (S810L) in the human mineralocorticoid receptor (MR) is responsible for early-onset hypertension that is exacerbated in pregnancy. All steroids, including progesterone, that display antagonist properties when bound to the wild-type MR are able to activate the mutant receptor (MRL810). These findings suggest that progesterone may contribute to the dramatic aggravation of hypertension in MRL810 carriers during pregnancy. However, the steroid(s) responsible for hypertension in MRL810 carriers (men and nonpregnant women) has not yet been identified. Here we show that cortisone and 11-dehydrocorticosterone, the main cortisol and corticosterone metabolites produced in the distal nephron, where sodium reabsorption stimulated by aldosterone takes place, bind with high affinity to MRL810. The potency with which cortisone and 11-dehydrocorticosterone bind to the mutant MR contrasts sharply with their low wild-type MR-binding capacity. In addition, cotransfection assays demonstrate that cortisone and 11-dehydrocorticosterone are potent activators of the MRL810 trans-activation function. Because the plasma concentration of cortisol in humans is about 30-fold higher than that of corticosterone, these findings strongly suggest that cortisone is one of the endogenous steroids responsible for early-onset hypertension in men and nonpregnant women carrying the MRL810 mutation.

    Introduction

    UNDER NORMAL conditions, aldosterone binds with high affinity to the mineralocorticoid receptor (MR) to stimulate renal sodium reabsorption. In response to aldosterone, MR modulates transcription, and this ultimately enhances the transport of sodium from the tubular lumen to the basolateral side of the principal cells of the collecting duct (1, 2). Screening for MR among 75 hypertensive patients, many with low plasma renin and/or low serum aldosterone levels, identified a missense mutation in exon 6 of the MR in a young boy, resulting in the substitution of leucine for serine (S810L) at codon 810 (MRL810) (3). Examination of this patient’s family revealed that all MRL810 carriers had developed hypertension before they were 20 yr old, a rare trait in the general population, whereas the members of the family who did not express the mutant MR had normal blood pressure (3). Rather intriguingly, the women harboring this mutation experienced a dramatic exacerbation of hypertension during pregnancy.

    In vitro experiments have revealed that aldosterone activates both wild-type MR (MRWT) and MRL810 (3). Furthermore, all steroids, including progesterone, that displayed antagonist properties when bound to MRWT were also able to activate MRL810. As the levels of plasma progesterone normally increase about 100-fold during pregnancy, Geller et al. (3) have postulated that this hormone may contribute to the dramatic exacerbation of hypertension in pregnant MRL810 carriers. The steroid(s) responsible for early-onset hypertension in MRL810 carriers (men and nonpregnant women) has still not been identified.

    Cortisol, which is 100- to 1000-fold more abundant than aldosterone in plasma, binds to MR with the same affinity as aldosterone (4, 5). In the collecting duct, the preferential accessibility of aldosterone to MR is ensured by 11ß- hydroxysteroid dehydrogenase type 2, an enzyme that metabolizes cortisol and corticosterone to form inactive cortisone and 11-dehydrocorticosterone (6, 7). Because the determinants for the ligand-induced activation of MRL810 are distinct from those for MRWT, we investigated the ability of cortisone and 11-dehydrocorticosterone to bind to MRL810 and activate its trans-activation function. The findings of steroid binding studies and steroid-induced trans-activation measurements provide evidence of the specific binding of cortisone and 11-dehydrocorticosterone to MRL810 and of their abilities to activate the mutant MR. Because the plasma level of cortisol in men is about 30-fold higher than the plasma level of corticosterone (8), these findings also suggested that cortisone could be involved in the development of hypertension in young men and nonpregnant women harboring the S810L mutation.

    Materials and Methods

    Plasmids and construction

    The expression plasmid pchMR contains the entire coding sequence of MRWT (9). Plasmid pchMRL810, encoding for MRL810, was constructed from pchMR using the QuikChange procedure from Stratagene (Amsterdam, The Netherlands). The Bpu1102I-AflII fragment of pchMRL810 was subcloned into pchMR, after being sequenced to confirm that there was no other mutation in the sequence. Plasmid pFC31Luc contains the mouse mammary tumor virus (MMTV) promoter that drives the luciferase gene (10), and plasmid TAT3-TATA-Luc contains a trimerized hormone response element fused to the alcohol dehydrogenase minimal promoter driving luciferase (11). The pSVß vector was from CLONTECH Laboratories, Inc. (Saint Quentin en Yvelines, France).

    In vitro hormone binding assay

    MRWT and MRL810 were expressed in vitro using the T7-coupled rabbit reticulocyte lysate system from Promega Corp. (Charbonnieres, France). Lysates containing MRWT or MRL810 were diluted 2-fold with TEGWD buffer [20 mM sodium tungstate and 1 mM dithiothreitol in 20 mM Tris-HCl, 1 mM EDTA, and 10% glycerol, pH 7.4 (TEG)], and incubated with 10 nM [3H]aldosterone (Amersham Pharmacia Biotech, Les Ulis, France) with or without unlabeled steroids for 30 min at 20 C. Bound and free steroids were separated by the dextran-charcoal method: 25 µl lysate were stirred for 5 min with 50 µl 4% Norit A and 0.4% dextran T-70 in TEG buffer and centrifuged at 4500 x g for 5 min at 4 C. Bound steroid was measured by counting the radioactivity of the supernatant.

    Kinetic experiments

    MRWT and MRL810 were expressed in vitro using the T7-coupled rabbit reticulocyte lysate system. The lysate was diluted 2-fold with ice-cold TEGWD buffer and then incubated with 10 nM [3H]aldosterone or [3H]cortisol for 30 min at 20 C. One half of the labeled lysate was kept at 20 C to measure the stability of the [3H]steroid-MR complexes, and the other was incubated with 10 µM of the corresponding unlabeled steroid for various periods. Bound and free steroids were separated with dextran-charcoal. Parallel incubations containing [3H]steroid plus a 1000-fold excess of unlabeled steroid were used to calculate the nonspecific binding. Results were corrected for receptor stability and expressed as a percentage of the binding measured at time zero.

    Cell culture and transfection

    COS-7 cells were cultured in DMEM (Life Technologies, Inc.-BRL, Cergy Pontoise, France) supplemented with 10% heat-inactivated fetal calf serum, 2 mM glutamine, 100 IU/ml penicillin, and 100 µg/ml streptomycin in a humidified atmosphere with 5% CO2. Cells were maintained in the medium supplemented with 10% charcoal-stripped fetal calf serum for 4 h before and then throughout the transfection procedure. Cells were transfected by the phosphate calcium precipitation method (Profection, Promega Corp.). The phosphate solution, prepared for six-well trays, contained 5 µg of one of the receptor expression vectors (pchMR or pchMRL810), 10 µg pFC31Luc or TAT3-TATA-Luc, and 2 µg pSVß. The steroids to be tested were added to the cells 12 h after transfection, and the incubation was continued for an additional 24 h. Cell extracts were then prepared and assayed for luciferase (12) and ß-galactosidase activities (13). To standardize the transfection efficiency, the relative light units obtained in the luciferase assay were divided by the OD obtained in the ß-galactosidase assay.

    Statistical analysis

    Values are the mean ± SEM from at least three separate experiments. Statistical differences between groups were analyzed by t test. P < 0.05 was considered significant.

    Results

    MRL810 and MRWT were expressed in vitro and tested for the ability to bind cortisone and 11-dehydrocorticosterone. As these two steroids were available as unlabeled molecules only, their abilities to inhibit [3H]aldosterone binding were measured in competition experiments. MRL810 or MRWT was incubated with 5 nM [3H]aldosterone alone or with 1 µM aldosterone, cortisol, cortisone, corticosterone, or 11dehydrocorticosterone. About 80% of the [3H]aldosterone bound to MRL810 or MRWT was displaced by a 200-fold excess of aldosterone, cortisol, or corticosterone (Fig. 1A), indicating that these hormones bind to MRWT and to MRL810. Cortisone did not displace the [3H]aldosterone bound to MRWT, but did inhibit the binding of [3H]aldosterone to MRL810. 11-Dehydrocorticosterone displaced by 40% and 80% the [3H]aldosterone bound to MRWT and MRL810, respectively (Fig. 1A). The range of concentrations of the corticosteroids tested widely differs in humans. Table 1 summarizes the plasma levels of aldosterone, cortisol, cortisone, and corticosterone in men. It appears that cortisol is about 1000-fold more abundant than aldosterone in plasma. The prevalence of cortisol over corticosterone in plasma led us to further analyze the abilities of various concentrations of cortisol and cortisone to inhibit [3H]aldosterone to both MRWT and MRL810. The dose-response curve depicted in Fig. 1B shows that cortisone was almost efficient as aldosterone and cortisol in displacing [3H]aldosterone from MRL810. This finding demonstrates the high affinity with which cortisone binds to MRL810.

    fig.ommitteed

    Figure 1. Effects of steroids on the binding of tritiated aldosterone to MRWT and mutant MRL810. A, MRWT and MRL810 were synthesized in vitro in rabbit reticulocyte lysate and incubated with 5 nM [3H]aldosterone with or without 1 µM unlabeled aldosterone, cortisol, cortisone, corticosterone, and 11-dehydrocortisone for 2 h at 4 C. B, MRL810 expressed in rabbit reticulocyte lysate was incubated with 5 nM [3H]aldosterone in the absence (100%) or presence of various concentrations of aldosterone, cortisol, or cortisone for 2 h at 4 C. Bound and unbound steroids were separated using the charcoal-dextran method. Results are expressed as a percentage of the specific [3H]aldosterone binding measured in the absence of any competitor. Each pointis the mean ± SEM of three separate experiments. ***, P < 0.001

    fig.ommitteed

    Table 1. Plasma concentration of corticosteroids in humans

    It has been reported that the stability of the steroid-receptor complexes is highly dependent upon the nature of the steroid (5). We therefore investigated whether the stability of the steroid-receptor complexes could be altered by the nature of amino acid residue at the 810 position of the MR. The half-life times (t1/2) of steroid-MRWT and steroid-MRL810 complexes were calculated from dissociation kinetics studies (Fig. 2). Aldosterone dissociated more slowly from MRL810 (t1/2 = 420 min) than from MRWT (t1/2 = 90 min; Fig. 2). Cortisol also dissociated more slowly from MRL810 (t1/2 = 120 min) than from MRWT (t1/2 = 10 min; Fig. 2). Figure 2 also shows that the dissociation kinetics were slower for the aldosterone-MRL810 complex (t1/2 = 420 min) than for the cortisol-MRL810 complex (t1/2 = 120 min). Similar differences in the dissociation kinetics and t1/2 were observed with aldosterone- and cortisol-MRWT complexes (Fig. 2). Despite the fact that S810L mutation has improved the stability of the human MR-steroid complexes, which suggests a change in receptor conformation, aldosterone-MR complexes still remain more stable than cortisol-MR complexes (Fig. 2).

    fig.ommitteed

    Figure 2. Dissociation of aldosterone from MRWT and MRL810. MRWT (black symbols) and MRL810 (open symbols) were produced by translation in vitro and incubated with 10 nM [3H]aldosterone (circles) or [3H]cortisol (triangles) for 30 min at 20 C. The end of this incubation period was taken as time zero for kinetic analysis. An aliquot was kept at 20 C to measure the stability of steroid-receptor complexes, and another aliquot was incubated with unlabeled aldosterone or cortisol (10-6 M). Bound and free steroids were separated by the dextran-charcoal method described in Materials and Methods. Nonspecific binding was measured in parallel for each time tested. Results were corrected for receptor stability and expressed as a percentage of the binding measured at time zero. Values are the mean ± SEM of three experiments.

    The trans-activation activity of MRL810 and MRWT in response to steroids was then examined in cis-trans cotransfection assays. COS-7 cells were transiently transfected with pchMRL810 or pchMRWT plus a reporter gene containing luciferase under the control of the MR-sensitive MMTV promoter (pFC31Luc). The transfected cells were incubated with 10 nM of the steroid to be tested. Aldosterone, cortisol, and corticosterone produced maximum activation of both MRWT and MRL810 (Fig. 3A). Progesterone had low MRWT-activating efficiency, but, like aldosterone, acted as a potent activator of MRL810 (Fig. 3A). Cortisone was unable to activate MRWT, but activated MRL810 to about 75% the level of aldosterone-induced MRL810 activity (Fig. 3A). 11-Dehydrocorticosterone had a low MRWT-activating efficiency, but maximally activated MRL810 (Fig. 3A). Additional transfection assays were performed using the TAT3-TATA-Luc promoter. In this case, 10-9 M cortisone, which slightly activated MRWT (25% of the aldosterone-induced MRWT activity), activated MRL810 to almost the same extent as aldosterone (Fig. 3A). These results indicated that the agonist activity of cortisone is related to the S810L mutation independently of the promoter used. The dose-response curves of MRWT and MRL810 trans-activation activity performed with the MMTV promoter also showed that cortisone had no effect on MRWT activity, and that the concentration of cortisone required to produce half-maximum MRL810 trans-activation activity was higher (5 x 10-9 M) than that of aldosterone (5 x 10-11 M; Fig. 3B).

    fig.ommitteed

    Figure 3. Trans-activation activity of MRWT and MRL810 in response to steroids. A and B, COS-7 cells were transfected with pchMRWT or pchMRL810 and pFC31Luc or TAT3-TATA-Luc as reporter plasmids, and a ß-galactosidase internal reporter was used to correct for transfection efficiency. A, Before harvesting, the cells were treated for 24 h with 10-8 M aldosterone, progesterone, cortisol, cortisone, corticosterone, or 11-dehydrocorticosterone (using pFC31Luc as reporter plasmid) or with 10-9 M aldosterone or cortisone (using TAT3-TATA-Luc as reporter plasmid). B, Before harvesting, the cells transfected with pFC31Luc were treated for 24 h with increasing concentrations of aldosterone or cortisone. Trans-activation was determined by luciferase activity, normalized vs. the internal ß-galactosidase control, and expressed as a percentage of MRWT activity measured in the presence 10-8 M aldosterone. Each point is the mean ± SEM of three separate experiments. ***, P < 0.001.

    Discussion

    The findings show that cortisone, the main metabolite of cortisol in the kidney, activates mutant MRL810, suggesting that cortisone is primarily involved in the early development of hypertension in patients harboring this mutation.

    Using cotransfection assays, Geller et al. (3) have shown that MRL810 displays a constitutive activity not detected for MRWT, and these researchers point out that this activity, which they observed without adding any steroid, may play a role in the onset of hypertension in patients harboring mutant MRL810. However, such constitutive activity accounts for only 20% of the maximum aldosterone-induced activity, suggesting that an endogenous steroid ligand is necessary for maximum MRL810 activation to promote hypertension. In their search for the endogenous steroid ligand activator, Geller et al. (3) tested the abilities of various steroids to activate MRL810. Neither estradiol nor testosterone, two steroids with a 17ß-hydroxyl group, activated MRL810 or MRWT (3). In contrast, steroids with a 21-hydroxyl group, such as aldosterone and cortisol, activated MRWT and MRL810 to the same extent (Ref. 3 and the present study). Steroids without the 21-hydroxyl group, which display antagonist properties when bound to the MRWT, are also able to activate MRL810 (3). This is the case for the antihypertensive drug spironolactone (a synthetic steroid with 17-lactone) and progesterone (Ref. 3 and the present study). The facts that 17-hydroxyprogesterone is able to activate MRL810 and the plasma level of this progesterone derivative is the same as that of aldosterone raised the possibility that 17{alpha} -hydroxyprogesterone may contribute to hypertension in men (3). In the present study we investigated the possibility that one of the steroid metabolites produced in the principal cells of the collecting duct could produce agonist effects at MRL810, but not at MRWT. We found that this was indeed the case for cortisone and 11-dehydrocorticosterone. The 11-dehydrometabolites of cortisol and corticosterone have very low agonist and antagonist activities at high concentrations when bound to MRWT (14, 15). In sharp contrast, we found that cortisone and 11dehydrocorticosterone bind and activate MRL810. Under normal conditions, cortisol and corticosterone are metabolized by 11ß-hydroxysteroid dehydrogenase type 2 to form the almost inactive substance, cortisone and 11-dehydrocorticosterone, respectively, allowing aldosterone to occupy the MR, and this is responsible for the fine hormonal regulation of sodium absorption in the distal nephron (6, 7, 15). Because plasma levels of corticosterone are much lower than those of cortisol, it seems unlikely that 11-dehydrocortisosterone will have any effect on MRL810 activation in vivo. Cortisol, the main plasma corticosteroid in humans, is metabolized into cortisone in collecting duct cells (15). Cortisone, inactive on MRWT, becomes active on MRL810. The dose-response curve of MRL810 trans-activation activity in response to cortisone suggests that the concentration of circulating cortisone is sufficient (70 nM) to activate the mutant MR. Thus, in MRL810 carriers, the occupancy of MR by cortisone should lead to permanent activation of the mutant MR.

    The agonist activity of aldosterone at the hMR has been attributed to the capacity of its 21-hydroxyl group to form a strong hydrogen bond with Asn770, a residue of the H3 helix (9). The presence of a hydroxyl group in the C11 position facing alanine 773 (A773) of the H3 helix interferes with the positioning of cortisol within the ligand-binding pocket of the hMR (9, 15, 16). As a result, the contact between the 21-hydroxyl of cortisol and Asn770 is weakened, and the MRWT-activating potential of cortisol is lower than that of aldosterone (9). The accommodation of cortisone in the ligand binding pocket is even more difficult, making contact between Asn770 and the 21-hydroxyl group almost impossible. This hypothesis is illustrated in Fig. 4. The lack of contact between Asn770 and the 21-hydroxyl group is compatible with the antagonist activity of cortisone, as has been observed for progesterone and spirolactone (9).

    fig.ommitteed

    Figure 4. Schematic representation of the amino acid residues of MRWT involved in the anchoring of cortisol and cortisone. The black arrows represent the hydrogen bonds between steroids and amino acid residues of the ligand-binding domain of MRWT. The Ala773 facing the 11-ketone of cortisone impairs its positioning within the ligand binding pocket of MRWT, leading to a weak contact between the 21-hydroxyl group of cortisone and Asn770 (dashed arrow).

    The exact mechanism of MRL810 activation remains unknown. It has been proposed that the agonist activity of MRL810 when bound to steroids with no 21-hydroxyl group, such as progesterone, depends on contacts between the H3 and H5 helixes via the Leu810 and Ala773 residues (3). Cortisone can also activate MRL810 through similar contacts. Another possible explanation, and the two are not mutually exclusive, is that the S810L mutation could modify the conformation of the mutant receptor, making it possible to accommodate cortisone within the ligand binding pocket of the mutant MR. In this case, the contact between the 21-hydroxyl group of cortisone and Asn770, which is responsible for the activation of MRWT by aldosterone (9), may make the cortisone-dependent agonist activity of mutant MRL810 possible. The question also arises of whether the high stability of the steroid-MRL810 complex contributes to permanent activation of the mutant receptor. Although this possibility cannot be completely ruled out, Geller et al. (3) showed that MRWT and MRL810 displayed the same sensitivity to aldosterone.

    The activating S810L mutation that has been found to date in only one family (3) has brought new insights to the understanding of MR agonism mechanisms. In this study we show that cortisone, which is normally an inefficient activator of MRWT, is able to activate MRL810. Thus, it is reasonable to infer that the early onset of hypertension in MRL810 carriers could be attributable to a permanent increase in renal sodium reabsorption due to activation of MRL810 by cortisone.

    Acknowledgments

    We thank H. Richard-Foy and F. Gouilleux for providing the plasmid pFC31Luc. We are grateful to D. Pearce for providing the plasmid TAT3-TATA-Luc.

    Received July 11, 2002.

    Accepted for publication October 31, 2002.

    References

    Rossier BC, Palmer LG 1992 Mechanism of aldosterone action on sodium and potassium transport in the kidney. In: Seldin DW, Giebisch G, eds. Physiology and pathology. 2nd ed. New York: Raven Press; 1373–409

    Bonvalet JP 1998 Regulation of sodium transport by steroid hormones. Kidney Int 65:49–56

    Geller DS, Farhi A, Pinkerton N, Fradley M, Moritz M, Spitzer A, Meinke G, Tsai FTF, Sigler PB, Lifton RP 2000 Activating mineralocorticoid receptor mutation in hypertension exacerbated by pregnancy. Science 289:119–123

    Arriza JL, Simerly RB, Swanson LW, Evans RM 1988 The neuronal mineralocorticoid receptor as a mediator of glucocorticoid response. Neuron 1: 887–900

    Hellal-Levy C, Couette B, Fagart J, Souque A, Gomez-Sanchez C, Rafestin-Oblin ME 1999 Specific hydroxylations determine selective corticosteroid recognition by human glucocorticoid and mineralocorticoid receptors. FEBS Lett 464:9–13

    Edwards CR, Stewart PM, Burt D, Brett L, McIntyre MA, Sutano WS, de Kloet ER 1988 Localization of 11ß-hydroxysteroid dehydrogenase-tissue specific protector of the mineralocorticoid receptor. Lancet 2:986–989

    Funder JW, Pearce PT, Smith R, Smith AI 1988 Mineralocorticoid action: target tissue specificity is enzyme, not receptor, mediated. Science 242:583–585

    Orth DN, Kovacs JK, De Bold R 1987 The adrenal cortex. In: Wilson JD, Foster W, eds. Textbook of endocrinology. 8th ed. Philadelphia: Saunders; 509

    Fagart J, Wurtz JM, Souque A, Hellallevy C, Moras D, Rafestin-Oblin ME 1998 Antagonism in the human mineralocorticoid receptor. EMBO J 17:3317–3325

    Gouilleux F, Sola B, Couette, Richard-Foy H 1991 Cooperation between structural elements in hormono-regulated transcription from the mouse mammary tumor virus promoter. Nucleic Acids Res 19:1563–1569

    Liu W, Wang J, Sauter NK, Pearce D 1995 Steroid receptor heterodimerzation in vitro and in vivo. Proc Natl Acad Sci USA 92:12480–12484

    De Wet JR, Wood KV, Deluca M, Helsinki DR, Subramani S 1987 Firefly luciferase gene: structure and expression in mammalian cells. Mol Cell Biol 7:725–737

    Herbomel P, Bourachot B, Yanif M 1984 Two distinct enhancers with different cell specificities coexist in the regulatory region of polyoma. Cell 39:653–662

    Morris DJ, Souness GW, Bren AS, Oblin ME 2000 Interactions of mineralocorticoids and glucocorticoids in epithelial target tissues. Kidney Int 57:1370–1373

    Farman N, Rafestin-Oblin ME 2001 Multiple aspects of mineralocorticoid selectivity. Am J Phyiol 280:181–192

    Auzou G, Fagart J, Souque A, Hellal-Levy C, Wurtz JM, Moras D, Rafestin-Oblin ME 2000 A single amino acid mutation of Ala773 in the mineralocorticoid receptor confers agonist properties to 11ß-substituted spirolactones. Mol Pharmacol 58:684–691(Marie-Edith Rafestin-Oblin Anny Souque Brigitte Bocchi Gregory Pinon Jerome Fagart and Alain Vandewa)
    娣団剝浼呮禒鍛返閸欏倽鈧喛绱濇稉宥嗙€幋鎰崲娴f洑绠e楦款唴閵嗕焦甯归懡鎰灗閹稿洤绱╅妴鍌涙瀮缁旂姷澧楅弶鍐ㄧ潣娴滃骸甯拋妞剧稊閺夊啩姹夐敍宀冨閹劏顓绘稉鐑橆劃閺傚洣绗夌€规粏顫﹂弨璺虹秿娓氭稑銇囩€硅泛鍘ょ拹褰掓鐠囦紮绱濈拠鐑藉仏娴犺埖鍨ㄩ悽浣冪樈闁氨鐓¢幋鎴滄粦閿涘本鍨滄禒顒佹暪閸掍即鈧氨鐓¢崥搴礉娴兼氨鐝涢崡鍐茬殺閹劎娈戞担婊冩惂娴犲孩婀扮純鎴犵彲閸掔娀娅庨妴锟�

   瀵邦喕淇婇弬鍥╃彿  閸忚櫕鏁為惂鐐  鐠囧嫯顔戦崙鐘插綖  閹兼粎鍌ㄩ弴鏉戭樋   閹恒劌鐡ㄧ紒娆愭箙閸欙拷   閸旂姴鍙嗛弨鎯版